Skip to main content

Protalix BioTherapeutics, Inc.

PLX
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001006281

No open-market purchases or sales by Protalix BioTherapeutics, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $33.7M in total; no superinvestor holds it.

13F holders, Q3 2021

Institutional positions in Protalix BioTherapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
35
+2 vs. Q2 2021
Shares held
4.42M
−145.9K (−3.2%) vs. Q2 2021
Total value
$5.91M
−$2.80M (−32.1%) vs. Q2 2021
New holders
7
10 more added
Sold out
5
11 more reduced

Compare with Q2 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PLX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2021: 35 institutions
Q1 2021: 38 institutionsQ2 2021: 33 institutionsQ3 2021: 35 institutionsQ4 2021: 31 institutionsQ1 2022: 32 institutionsQ2 2022: 30 institutionsQ3 2022: 27 institutionsQ4 2022: 26 institutionsQ1 2023: 34 institutionsQ2 2023: 66 institutionsQ3 2023: 61 institutionsQ4 2023: 66 institutionsQ1 2024: 64 institutionsQ2 2024: 66 institutionsQ3 2024: 45 institutionsQ4 2024: 46 institutionsQ1 2025: 63 institutionsQ2 2025: 63 institutionsQ3 2025: 77 institutionsQ4 2025: 83 institutionsQ1 2026: 100 institutionsQ2 2026: 101 institutions
Value heldQ3 2021: $5.91M
Q1 2021: $39.4MQ2 2021: $8.71MQ3 2021: $5.91MQ4 2021: $2.52MQ1 2022: $1.29MQ2 2022: $1.30MQ3 2022: $3.70MQ4 2022: $4.87MQ1 2023: $6.15MQ2 2023: $17.9MQ3 2023: $15.2MQ4 2023: $18.1MQ1 2024: $12.4MQ2 2024: $6.60MQ3 2024: $3.53MQ4 2024: $8.40MQ1 2025: $21.0MQ2 2025: $17.6MQ3 2025: $31.0MQ4 2025: $26.8MQ1 2026: $36.6MQ2 2026: $33.7M
Institutions holding PLX and their total value by quarter
QuarterHoldersValue
Q2 2026101$33.7M
Q1 2026100$36.6M
Q4 202583$26.8M
Q3 202577$31.0M
Q2 202563$17.6M
Q1 202563$21.0M
Q4 202446$8.40M
Q3 202445$3.53M
Q2 202466$6.60M
Q1 202464$12.4M
Q4 202366$18.1M
Q3 202361$15.2M
Q2 202366$17.9M
Q1 202334$6.15M
Q4 202226$4.87M
Q3 202227$3.70M
Q2 202230$1.30M
Q1 202232$1.29M
Q4 202131$2.52M
Q3 202135$5.91M
Q2 202133$8.71M
Q1 202138$39.4M

Institutions, Q3 2021

Shares, value and share of portfolio for each institution holding Protalix BioTherapeutics, Inc.; share changes are against Q2 2021.

Institutions holding PLX in Q3 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Morgan Stanley2,285,075$3.04M0.00%+423,256+22.7%Added
Gsa Capital Partners LLP254,871$339.0K0.03%+254,871New
Susquehanna International Group, LLP251,171$334.0K0.00%−31,974−11.3%Reduced
Meitav Dash Investments Ltd244,332$325.0K0.01%−244,332−50.0%Reduced
Phoenix Holdings Ltd.244,113$325.0K0.01%00.0%Unchanged
Group One Trading, L.P.222,553$296.0K0.01%+43,465+24.3%Added
Walleye Capital LLC220,089$293.0K0.01%−126,450−36.5%Reduced
BlackRock Inc.119,555$159.0K0.00%−2,944−2.4%Reduced
Simplex Trading, LLC69,049$129.0K0.00%00.0%Unchanged
Walleye Trading LLC81,000$108.0K0.00%−54,000−40.0%Reduced
Susquehanna Fundamental Investments, LLC59,500$79.0K0.00%−6,600−10.0%Reduced
Bridgeway Capital Management, LLC58,890$78.0K0.00%−335,000−85.0%Reduced
Jane Street Group, LLC40,949$54.0K0.00%+9,284+29.3%Added
Davenport & Co LLC36,000$48.0K0.00%+24,000+200.0%Added
IHT Wealth Management, LLC33,200$44.0K0.00%+33,200New
Credit Suisse AG31,974$43.0K0.00%−33,951−51.5%Reduced
Wolverine Trading, LLC28,168$39.0K0.00%−17,138−37.8%Reduced
Citadel Advisors LLC24,945$34.0K0.00%−90,941−78.5%Reduced
XTX Topco Ltd20,514$27.0K0.01%+3,366+19.6%Added
Spire Wealth Management18,000$24.0K0.00%+4,000+28.6%Added
Two Sigma Advisers, LP14,200$19.0K0.00%+14,200New
Cutler Group LP11,267$14.0K0.00%+4,367+63.3%Added
Bank of America Corp8,890$12.0K0.00%+3,017+51.4%Added
Federated Hermes, Inc.5,761$8.00K0.00%00.0%Unchanged
Psagot Investment House Ltd.6,000$8.00K0.00%00.0%Unchanged
JPMorgan Chase & Co5,847$8.00K0.00%+5,847New
Psagot Value Holdings Ltd. / (Israel)6,000$8.00K0.00%+6,000New
Migdal Insurance & Financial Holdings Ltd.4,000$5.00K0.00%+4,000New
Harbour Investments, Inc.3,000$4.00K0.00%+3,000New
UBS Group AG2,314$3.00K0.00%+389+20.2%Added
Federation des caisses Desjardins du Quebec1,100$1.46K0.00%00.0%Unchanged
Royal Bank of Canada500$1.00K0.00%−620−55.4%Reduced
Captrust Financial Advisors800$1.00K0.00%00.0%Unchanged
Steward Partners Investment Advisory, LLC1,000$1.00K0.00%00.0%Unchanged
Ten Capital Wealth Advisors, LLC552$1.00K0.00%+227+69.8%Added
Renaissance Technologies LLC0$00.00%−30,075−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−4,658−100.0%Sold out
Red Door Wealth Management, LLC0$00.00%−2,000−100.0%Sold out
Deutsche Bank AG0$00.00%−873−100.0%Sold out
Gemmer Asset Management LLC0$00.00%−800−100.0%Sold out